Prosecution Insights
Last updated: August 17, 2026
Application No. 18/283,283

COMPOUND, METHOD FOR PREPARING SAME, AND SINGLE MOLECULE AND POLYMER DERIVED FROM SAME

Non-Final OA §102
Filed
Sep 21, 2023
Priority
Nov 11, 2021 — RE 10-2021-0154715 +1 more
Examiner
PARSA, JAFAR F
Art Unit
1692
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
LG Chem Ltd.
OA Round
1 (Non-Final)
87%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1087 granted / 1246 resolved
+27.2% vs TC avg
Moderate +9% lift
Without
With
+8.9%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 11m
Avg Prosecution
20 currently pending
Career history
1260
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
51.3%
+11.3% vs TC avg
§102
11.9%
-28.1% vs TC avg
§112
16.0%
-24.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1246 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant's election with traverse of Group I, claims 1-4 and 6-9 in the reply filed on May 13, 2026 is acknowledged. The traversal is on the ground(s) that the non-elected claim 5, does not represent a serious burden. This is not found persuasive because Group I and II do not share a coextensive search scope. The compound of Group I, is defined by its structure, not its source. It can be synthesized using alternative starting materials. The requirement is still deemed proper and is therefore made FINAL. Claim 5 is withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4 and 6-9 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Komatsu et al (US 2019/0194365 A1). Komatsu discloses a compound of:$ 4-(1H,1H,2H,2H-nonafluorohexyl) styrene is shown below: PNG media_image1.png 205 473 media_image1.png Greyscale Compound of chemical formula 1, of claims 1-4 and 6-9, wherein R1 is C4F9, n is 4, R2 is hydrogen and r2 is 4. See paragraphs 0208 and 0227. Komatsu relates to a composition, a modification method and a selective modification method of a base material surface, as well as a pattern-forming method, and a polymer [0002] and [0009]. Claim Rejections - 35 USC § 102 A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 3 and 7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Zong (WO 2020082678). Zong discloses a following compound: PNG media_image2.png 120 320 media_image2.png Greyscale R1 is C5F11, R2 is ester group and H, see page 5. Claim Rejections - 35 USC § 102 A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4 and 7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kobayashi et al (JP 2008221067). Kobayashi discloses a following compound: RN 1061723-69-0 PNG media_image3.png 160 562 media_image3.png Greyscale R1 is C8F17 , R2 is H and r2 is 4 Claim Rejections - 35 USC § 102 A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 3 and 7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kureha Chemical industry (JP 58029723). Kureha Chemical industry discloses the following compound: PNG media_image4.png 160 334 media_image4.png Greyscale R1 is CF3, R2 is H and r2=4 See page 2, right column. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAFAR F PARSA whose telephone number is (571)272-0643. The examiner can normally be reached M-F 10:00 AM-6:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JAFAR F PARSA/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Sep 21, 2023
Application Filed
Jul 22, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703674
PROCESSES FOR PRODUCING CARBOXYLIC ACIDS OR ALKYL ESTERS
2y 8m to grant Granted Aug 11, 2026
Patent 12691439
CATALYST FOR PRODUCTION OF CARBOXYLIC ACID ESTER AND METHOD FOR PRODUCING CARBOXYLIC ACID ESTER
3y 4m to grant Granted Jul 28, 2026
Patent 12692445
METHOD FOR THE PRODUCTION OF LOW CARBON JET FUEL
3y 2m to grant Granted Jul 28, 2026
Patent 12686824
PROCESS AND INSTALLATION FOR THE PRODUCT PROCESSING OF FISCHER-TROPSCH BASED RAW PRODUCTS FOR THE PRODUCTION OF PRE-FORMULATED FUELS OR STANDARD-COMPLIANT FUELS
3y 2m to grant Granted Jul 21, 2026
Patent 12679726
Conversion of a hydrocarbon feed gas to synthesis gas for producing hydrocarbons
3y 6m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
87%
Grant Probability
96%
With Interview (+8.9%)
1y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1246 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month